Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New agents for CNS disorders claimed by HHS

Dec. 30, 1996

Copaxone approved by FDA

Dec. 24, 1996

AACTG begins phase II memantine trial

Dec. 24, 1996

T Cell Sciences reports progress on TCAR program

Dec. 24, 1996

Otsuka describes new analgesics

Dec. 24, 1996

Neuroprotective polypeptide reported by Amgen

Dec. 24, 1996

Algos and Interneuron codevelop novel antimigraine combination

Dec. 23, 1996

Northwest Neurologic and Wyeth-Ayerst neurodegenerative disorder collaboration

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

IND filed for chirally pure ADHD treatment

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...